Public Company News
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
SUZHOU, China, May 26, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "BioNTech"), a next-generation immunotherapy company pioneering novel therapies for ca...
2024-05-27 08:00
2611
Hyundai Mobis Hosts Investment Conference in Silicon Valley!
* Hyundai Mobis holds 'Mobis Mobility Day,' themed around eco-friendly mobility, to share the company's technological developments and future vision * The event seeks business collaboration opportunities with innovative companies, focusing on securing allies in future technologies such as ele...
2024-05-26 20:00
3922
X Financial Reschedules the Release of First Quarter 2024 Financial Results to May 31, 2024
SHENZHEN, China, May 24, 2024 /PRNewswire/ -- X Financial (NYSE: XYF) (the "Company"), a leading online personal finance company inChina, today announced that it has rescheduled the release of its unaudited financial results for the first quarter endedMarch 31, 2024 to Friday, May 31, 2024, befor...
2024-05-25 09:23
6714
Nano Labs Announces Receipt of Deficiency Letters from Nasdaq
HANGZHOU, China, May 24, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider in China, today announced that it received two notification letters datedMay 24, 2024 (the "Deficiency ...
2024-05-25 04:30
5391
Ace Global Business Acquisition Limited Announces Mutual Termination of Merger Agreement and Redemption of Ordinary Shares
NEW YORK, May 24, 2024 /PRNewswire/ -- Ace Global Business Acquisition Limited (NASDAQ: ACBA) (the "Company"), a special purpose acquisition company, announced today that the Business Combination Agreement datedDecember 23, 2022 between the Company and LE Worldwide Limited, aBritish Virgin Island...
2024-05-24 23:33
5718
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response
- Lunit's ASCO 2024 presentations to highlight advances including HER2 ultra-low detection and AI-powered ICI response prediction models for NSCLC, demonstrating the impact of Lunit SCOPE suite on precision oncology SEOUL, South Korea, May 24, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leadin...
2024-05-24 22:07
6693
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual Meeting
SHANGHAI, May 24, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest progress of the Phase I/II clinical study of 9MW2821, a novel Nectin-4-targeting ADC for multiple advanced solid tumors, which will be reported as an oral pre...
2024-05-24 22:00
6387
GV Innovative High-Value Business Model and Diversified Development Strategy
TORONTO, May 24, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company's innovativ...
2024-05-24 20:35
4864
Visionary Holdings Inc. Announces Share Consolidation of Ordinary Shares
TORONTO, May 24, 2024 /PRNewswire/ -- Visionary Holdings Inc. ("we", or the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners in China, today announced that it inten...
2024-05-24 20:30
4753
Xiao-I Corporation Partners with Leading Bank to Revolutionize Knowledge Management with Advanced AI Technology
SHANGHAI, May 24, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading AI company announces an important partnership with a major Chinese banking institution to enhance its knowledge management. This partnership is expected to revolutionize knowledge manag...
2024-05-24 20:20
8351
Mega Matrix Corp. Announced that FlexTV Formed the Strategic Cooperation with TopReels, the leading short drama platform in South Korea
PALO ALTO, Calif., May 24, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that Yuder PTE, LTD, the Company's indirect majority-controlled subsidiary and operator of FlexTV, has formed a strategic cooperation with Foxmedia Co., Ltd., 100% cont...
2024-05-24 20:00
6058
Tyfon and Global Technology Acquisition Corp. I Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination
• Transaction expected to close in the second half of 2024 ZEPHYR COVE, Nev. and SUZHOU, China, May 24, 2024 /PRNewswire/ -- Global Technology Acquisition Corp. I (NASDAQ: GTAC) ("GTAC"), a special purpose acquisition company, and Tyfon Culture Holdings Limited ("Tyfon"), a well-recogniz...
2024-05-24 19:39
7530
XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched
SAO PAULO, May 24, 2024 /PRNewswire/ -- In a significant move to strengthen its foothold in the Latin American market,XCMG Machinery ("XCMG", SHE:000425) has ramped up its operations, marking the 50th anniversary of the establishment of diplomatic relations betweenChina and Brazil. The company's ...
2024-05-24 19:27
5154
CNFinance to Hold Annual General Meeting on June 7, 2024
GUANGZHOU, China, May 24, 2024 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it will hold its annual general meeting of shareholders (the "AGM") at 44/F, Tower G, No. 16 Zhujiang Do...
2024-05-24 18:00
4870
Atour Unveils Sustainability Records in 2023 With Milestone ESG Report
SHANGHAI, May 24, 2024 /PRNewswire/ -- May 23, Atour Lifestyle Holdings Limited (NASDAQ: ATAT), a leading hospitality and lifestyle company inChina, has released its inaugural Environmental, Social, and Governance (ESG) report for 2023. The report underscores the company's sustainability efforts...
2024-05-24 18:00
5161
36Kr Hosts "AI Partner • Advanced Productivity" Conference
BEIJING, May 24, 2024 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today hosted its "AI Partner • Advanced Productivity" Conference inBeijing, exploring AI technology...
2024-05-24 18:00
6507
New Oriental Extends Share Repurchase Program
BEIJING, May 24, 2024 /PRNewswire/ -- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that its board of directors has authorized the Company to extend its share repurch...
2024-05-24 17:00
2631
Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
* Anittumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA. * Sunvozertinib could effectively clear EGFR exon20ins in plasma ctDNA, confirming its direct effect on EGFR pathway. * The resistance to sunvozertinib could be thro...
2024-05-24 16:32
2871
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its four abstracts selected for presentations a...
2024-05-24 09:15
3065
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024
Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression, including in patients with PD-L1 CPS<5. PRINCETON, N.J. and SUZHOU, China, May 23, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharm...
2024-05-24 08:00
3025
Week's Top Stories
Most Reposted
Visa and Lianlian Advance Trusted B2B Agentic Commerce Through LoopXPay's First Live B2B Agentic Transaction
[Picked up by 318 media titles]
2026-07-24 12:00
Ascentium Welcomes MGI Dobbyn Carafa, Strengthening Advisory Capability in Australia
[Picked up by 297 media titles]
2026-07-20 15:00
A New Chapter Begins: Peach Blossoms Returns to Level 5 with the Debut of its Black Pearl One Diamond Tasting Journey
[Picked up by 295 media titles]
2026-07-23 16:00
Phuket Marriott Resort & Spa, Merlin Beach Elevates Guest Experience with New Dining and Family Facilities
[Picked up by 292 media titles]
2026-07-24 18:32
Courtyard by Marriott Phuket, Patong Beach Wins TripAdvisor Best of the Best Award
[Picked up by 289 media titles]
2026-07-24 16:25
Most Read
Ascentium Welcomes MGI Dobbyn Carafa, Strengthening Advisory Capability in Australia
2026-07-20 15:00
16201
A New Chapter Begins: Peach Blossoms Returns to Level 5 with the Debut of its Black Pearl One Diamond Tasting Journey
2026-07-23 16:00
7252
Omni HR Launches Native MCP Integration, Connecting AI Assistants to Live HR Data
2026-07-20 11:00
7246
